Are you in need of the most recent regulations regarding post-marketing and clinical trials in Thailand? Thailand has recently updated its pharmacovigilance framework to align more closely with international standards and enhance drug safety monitoring. The Thai Food and Drug Administration (TFDA), has introduced several new guidelines and tools:

• Good Pharmacovigilance Practice (GVP) Thailand: This is a voluntary foundational guideline aimed at improving the quality and consistency of safety monitoring across the pharmaceutical industry.
• PMAS System: A proactive monitoring system for health product safety, helping stakeholders detect and report adverse events more efficiently.
• Thai Vigibase: A national database used for research and analysis of adverse drug reactions, supporting evidence-based regulatory decisions.
• ASEAN Rapid Alert System: Thailand participates in this regional initiative to share urgent safety alerts across member countries.